Gyre Therapeutics (GYRE) Change in Cash (2010 - 2026)
Gyre Therapeutics (GYRE) reported Change in Cash of $431000.0 for Q1 2026, down 86.66% year-over-year from $3.2 million in Q1 2025, and up 112.94% on a QoQ basis from -$3.3 million in Q4 2025.
Gyre Therapeutics (GYRE) has 17 years of Change in Cash data on file, last reported at $431000.0 in Q1 2026.
- Quarterly Change in Cash fell 86.66% year-over-year to $431000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.5 million (up 252.35% YoY) and the FY2025 annual result came in at $25.3 million, up 216.41% from the prior year.
- Change in Cash advanced to $431000.0 in Q1 2026 per GYRE's latest filing, from -$3.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $40.6 million in Q2 2022 and bottomed at -$52.3 million in Q3 2022.
- The 5-year median for Change in Cash is $431000.0 (2026), against an average of $429294.1.
- The widest annual swing landed in 2022, when Change in Cash plunged 261.62%; it then surged 1793.07% in 2025.
- Tracing GYRE's Change in Cash over 5 years: stood at $16.2 million in 2022, then plunged by 54.22% to $7.4 million in 2023, then tumbled by 154.55% to -$4.1 million in 2024, then climbed by 17.79% to -$3.3 million in 2025, then soared by 112.94% to $431000.0 in 2026.
- Per Business Quant, the three latest GYRE Change in Cash figures stand at $431000.0 (Q1 2026), -$3.3 million (Q4 2025), and $3.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | 431,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 431,000.00 |
| Dec 31, 2025 | -3.33 Mn |
| Sep 30, 2025 | 3.91 Mn |
| Jun 30, 2025 | 21.45 Mn |
| Mar 31, 2025 | 3.23 Mn |
| Dec 31, 2024 | -4.05 Mn |
| Sep 30, 2024 | -231,000.00 |
| Jun 30, 2024 | -13.69 Mn |
| Mar 31, 2024 | -3.72 Mn |
| Dec 31, 2023 | 7.43 Mn |
| Sep 30, 2023 | 2.35 Mn |
| Jun 30, 2023 | -4.42 Mn |
| Mar 31, 2023 | 2.97 Mn |
| Dec 31, 2022 | 16.23 Mn |
| Sep 30, 2022 | -52.30 Mn |
| Jun 30, 2022 | 40.58 Mn |
| Mar 31, 2022 | -9.53 Mn |
| Dec 31, 2021 | -14.81 Mn |
| Sep 30, 2021 | -14.46 Mn |
| Jun 30, 2021 | -9.42 Mn |
| Mar 31, 2021 | 52.68 Mn |
| Dec 31, 2020 | 5.44 Mn |
| Sep 30, 2020 | -34.35 Mn |
| Jun 30, 2020 | -11.09 Mn |
| Mar 31, 2020 | 55.00 Mn |
| Dec 31, 2019 | -7.65 Mn |
| Sep 30, 2019 | 5.62 Mn |
| Jun 30, 2019 | -7.68 Mn |
| Mar 31, 2019 | -6.19 Mn |
| Dec 31, 2018 | -4.79 Mn |
| Sep 30, 2018 | -10.66 Mn |
| Jun 30, 2018 | -80.02 Mn |
| Mar 31, 2018 | 106.92 Mn |
| Dec 31, 2017 | 3.10 Mn |
| Sep 30, 2017 | -21.69 Mn |
| Jun 30, 2017 | 10.99 Mn |
| Mar 31, 2017 | -2.46 Mn |
| Dec 31, 2016 | 947,000.00 |
| Sep 30, 2016 | -2.02 Mn |
| Jun 30, 2016 | -9.25 Mn |
| Mar 31, 2016 | -8.52 Mn |
| Dec 31, 2015 | 6.00 Mn |
| Sep 30, 2015 | 20.79 Mn |
| Jun 30, 2015 | 237,000.00 |
| Mar 31, 2015 | 525,000.00 |
| Dec 31, 2014 | -2.06 Mn |
| Sep 30, 2014 | 11.84 Mn |
| Jun 30, 2014 | -1.62 Mn |
| Mar 31, 2014 | -9.44 Mn |
| Dec 31, 2013 | 19.93 Mn |
| Sep 30, 2013 | -1.32 Mn |
| Jun 30, 2013 | -6.80 Mn |
| Mar 31, 2013 | -12.38 Mn |
| Dec 31, 2012 | 4.04 Mn |
| Sep 30, 2012 | 6.56 Mn |
| Jun 30, 2012 | -17.02 Mn |
| Mar 31, 2012 | -18.62 Mn |
| Dec 31, 2011 | -23.26 Mn |
| Sep 30, 2011 | -37.60 Mn |
| Jun 30, 2011 | 29.31 Mn |
| Mar 31, 2011 | -27.02 Mn |
| Dec 31, 2010 | -19.95 Mn |
| Sep 30, 2010 | -35.83 Mn |